A number of research firms have changed their ratings and price targets for Clovis Oncology (NASDAQ: CLVS):
Shares of Clovis Oncology Inc. (NASDAQ:CLVS) opened at 35.77 on Friday. The company’s market cap is $1.38 billion. Clovis Oncology Inc. has a 12-month low of $11.57 and a 12-month high of $109.18. The company’s 50-day moving average price is $29.07 and its 200 day moving average price is $18.62.